The focus will initially be on creating computational and digital pathology products, as well as AI-assisted algorithms.

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.

Under the terms of the agreement, AstraZeneca will leverage Immunai ... ultimately maximizing research and development productivity. Immunai, known for its groundbreaking use of single-cell ...

With the growing understanding that ATTR-CM may be a significant underlying cause of HFpEF, how might AstraZeneca’s research influence the development of therapies for this subset of heart ...

head of research and development at Alexion, would succeed Mene Pangalos, the long-time biopharmaceuticals head of research at AstraZeneca. Sign up here. Pangalos was the public face of the ...

March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...

Through its recently announced research and development (R&D) expansion, AstraZeneca is focused on tapping into this ecosystem to advance the development of the company’s leading global pipeline ...

[Photo/China Daily] AstraZeneca, a United Kingdom-based biopharmaceutical giant, will add 10 to 15 new projects to the company's research and development pipeline in China each year, reflecting ...

AstraZeneca did not immediately respond to a Reuters requests for comment. The Financial Times, which first reported the deal, said it includes an upfront fee for Absci, research and development ...